Kicking off today – Caszyme is attending the ASGCT Annual Meeting 2026!
From May 11–15, we’re joining one of the leading gatherings in the cell and gene therapy field to connect with partners, meet new collaborators, and share the latest advances from our platform.
Join our CEO, Dr. Giedrius Gasiunas, as he presents new data on the CRISPR-Cas12l genome editor, including in vivo activity evaluation studies in mice. This work further highlights platform’s therapeutic potential.
Wednesday, May 13 at 08:30-08:45 AM ET
MCEC Room 210ABC, Level 2
If you’re attending, feel free to connect with Dr. Giedrius Gasiunas via the ASGCT Event App or send us a DM.